Tag: Celanova
Positive clinical results from eCOBRA study
CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market s...
Study to explore shortest-ever duration of triple therapy after PCI
The COBRA REDUCE trial is exploring the safety and efficacy of prescribing dual antiplatelet the...
Cobra PzF nano-coated stent now being studied with 14-day DAPT in patients at high risk of bleeding
The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra ...
Cobra PzF stent approved for commercial use in the USA
The FDA has approved a nano-coated coronary stent system—CeloNova Biosciences’ Cobra PzF—for use...
